[Does hypothyroidism potentialize muscular toxicity of fibrates?].
Harlé
J R
JR
Toussirot
E
E
Disdier
P
P
Drancourt
M
M
Weiller
P J
PJ
D000368:Aged; D001629:Bezafibrate / Q000009:adverse effects*; D002995:Clofibric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D058607:Fibric Acids; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D007037:Hypothyroidism / Q000503:physiopathology*; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced*
D058607:Fibric Acids; D000960:Hypolipidemic Agents; D002995:Clofibric Acid; C019304:ciprofibrate; D001629:Bezafibrate
L'hypothyroïdie potentialise-t-elle la toxicité musculaire des fibrates?